Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenABCWY dosing schedule study in healthy adolescents
2023-504301-37-00Phase 2Authorised
- Sponsor
- GSK
- Start
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 2, randomised, single-blind trial of Meningococcal ABCYW vaccine in meningococcal disease (3 arms), sponsored by GSK. Planned start Dec 2023; status: authorised.
02
Drugs
Meningococcal ABCYW vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2023-504301-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504301-37-00.